Table 4.
Projected Kidney Failure | ESRD | Death | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Black | White | Hispanic | Asian | Total | Black | White | Hispanic | Asian | Total | |
Yes | 501.19 (472.18–531.97) | 213.91 (203.61–224.72) | 444.22 (422.61–466.94) | 468.48 (428.55–512.13) | 333.73 (324.31–343.42) | 1,068.68 (1,025.93–1,113.21) | 1,513.73 (1,485,93–1,524.06) | 785.73 (756.81–815.76) | 793.71 (741.20–849.94) | 1,212.32 (1,194.24–1,230.66) |
No | 0.90 (0.70–1.16) | 0.60 (0.51–0.70) | 0.33 (0.25–0.43) | 0.43 (0.28–0.65) | 0.54 (0.48–0.60) | 89.39 (87.14–91.69) | 127.10 (125.71–128.50) | 45.05 (44.03–46.10) | 44.51 (42.72–46.36) | 89.47 (88.47–90.07) |
Total | 16.62 (15.69–17.62) | 6.68 (6.38–7.01) | 9.60 (9.14–10.08) | 9.61 (8.81–10.49) | 9.10 (8.85–9.36) | 120.16 (117.59–122.78) | 166.67 (165.11–168.25) | 60.52 (59.35–61.72) | 52.64 (57.17–61.32) | 118.14 (117.23–119.05) |
Note: Values shown as event rate per 10,000 person-years (95% CI). Projected kidney failure was defined by an ordinary least squares regression line that would result in estimated glomerular filtration rate<15 mL/min/1.73m2 within the study period (by 31st Dec 2009). Ninety-four percent of all participants experienced neither death nor ESRD within the study period.
CI, confidence interval; ESRD, end-stage renal disease;